Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis
Abstract Background Accumulating evidence has demonstrated that aberrant expression of deubiquitinating enzymes is associated with the initiation and progression of Triple-negative breast cancer (TNBC). The publicly available TCGA database of breast cancer data was used to analyze the OTUD deubiquit...
Main Authors: | Zhitao Han, Qi Jia, Jing Zhang, Miaomiao Chen, Lining Wang, Kai Tong, Weiwei He, Yajie Zhang, Weina Zhu, Ju Qin, Tao Wang, Tielong Liu, Yong Ma, Yuanming Chen, Siluo Zha, Chunlei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-023-02781-3 |
Similar Items
-
Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
by: Xuejing Shao, et al.
Published: (2022-04-01) -
YOD1 serves as a potential prognostic biomarker for pancreatic cancer
by: Zhishuo Zhang, et al.
Published: (2022-05-01) -
CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
by: Xiao Li, et al.
Published: (2022-04-01) -
El cambio fónico de yod primera: la evolución histórica a través del español actual
by: Raquel González Gerabert
Published: (2019-12-01) -
Deubiquitylation of deubiquitylases
by: Saba Haq, et al.
Published: (2017-01-01)